| Bioactivity | Suritozole (MGL-26479) is a cognitive enhancer that acts as a partial inverse agonist of benzodiazepine receptor sites on GABAA ion channel complexes. Suritozole can be used in the study of neurodegenerative diseases[1]. |
| CAS | 110623-33-1 |
| Formula | C10H10FN3S |
| Molar Mass | 223.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. O'Dell DM, et al. Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury. J Neurosurg. 1995 Nov;83(5):878-83. |
Suritozole
CAS: 110623-33-1 F: C10H10FN3S W: 223.27
Suritozole (MGL-26479) is a cognitive enhancer that acts as a partial inverse agonist of benzodiazepine receptor sites o
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.